Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study
- PMID: 11289478
- DOI: 10.2337/diacare.24.3.516
Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study
Abstract
Objective: To evaluate the intravitreous concentration of vascular cell adhesion molecule (VCAM)-1 in diabetic patients with proliferative diabetic retinopathy (PDR) and the relationship of VCAM-1 with vascular endothelial growth factor (VEGF).
Research design and methods: Serum and vitreous fluid samples were obtained simultaneously at the onset of vitrectomy from 20 diabetic patients with PDR and 20 nondiabetic control subjects with nonproliferative ocular disease. Both groups were matched by serum levels of VCGM-1 and VEGF. VCAM-1 and VEGF were determined by enzyme-linked immunosorbent assay. Statistics were determined using the Mann-Whitney U test and Spearman's rank correlation test.
Results: The intravitreous concentration of VCAM-1 was signifcantly elevated in diabetic patients with PDR compared with control subjects (26 ng/ml [19-118] vs. 22 ng/ml [20-47], P < 0.05). A direct correlation between VCAM-1 and total vitreous proteins was detected in diabetic patients (r = 0.64, P = 0.003), but not in control subjects. After adjusting for total intravitreous proteins, VCAM-1 was significantly lower in diabetic patients with PDR than in control subjects (8.2 ng/ml [4-31.4] vs. 43.1 ng/ml [9.7-100], P < 0.001). Intravitreous VEGF concentrations were higher in patients with PDR than in control subjects in absolute terms (1.34 ng/ml [0.16-6.22] vs. 0.009 ng/ml [0.009-0.044], P < 0.0001) and after correcting for total vitreal proteins (0.33 ng/ml [0.01-2.3] vs. 0.013 ng/ml [0.003-0.035], P = 0.0001). Finally, the vitreous ratio of VCAM-1 to proteins correlated with the vitreous ratio of VEGF to proteins in both diabetic patients (r = 0.74, P = 0.001) and control subjects (r = 0.84, P = 0.005).
Conclusions: The low proportion of VCAM-1 in relation to total vitreal proteins observed in diabetic patients with PDR suggests that VCAM-1 is quenched by diabetic retina. In addition, the direct correlation detected between VCAM-1 and VEGF suggests that cellular adhesion and neovascularization may be linked processes.
Similar articles
-
Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.Diabetologia. 1997 Sep;40(9):1107-9. doi: 10.1007/s001250050794. Diabetologia. 1997. PMID: 9300249
-
Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.Am J Ophthalmol. 2002 Sep;134(3):376-82. doi: 10.1016/s0002-9394(02)01538-6. Am J Ophthalmol. 2002. PMID: 12208249
-
Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.Diabet Med. 2002 Aug;19(8):655-60. doi: 10.1046/j.1464-5491.2002.00768.x. Diabet Med. 2002. PMID: 12147146
-
Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.Diabetes. 1997 Sep;46 Suppl 2:S26-30. doi: 10.2337/diab.46.2.s26. Diabetes. 1997. PMID: 9285495 Review.
-
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.Prog Retin Eye Res. 2019 Sep;72:100756. doi: 10.1016/j.preteyeres.2019.03.002. Epub 2019 Apr 2. Prog Retin Eye Res. 2019. PMID: 30951889 Review.
Cited by
-
Angiogenesis in diabetes and obesity.Rev Endocr Metab Disord. 2015 Mar;16(1):67-75. doi: 10.1007/s11154-015-9310-7. Rev Endocr Metab Disord. 2015. PMID: 25663658 Free PMC article. Review.
-
Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2014 Aug;252(8):1229-34. doi: 10.1007/s00417-014-2586-6. Epub 2014 Feb 15. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24531563
-
Gingerol, a Natural Antioxidant, Attenuates Hyperglycemia and Downstream Complications.Metabolites. 2022 Dec 16;12(12):1274. doi: 10.3390/metabo12121274. Metabolites. 2022. PMID: 36557312 Free PMC article. Review.
-
Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy.Clin Ophthalmol. 2012;6:185-91. doi: 10.2147/OPTH.S27423. Epub 2012 Jan 26. Clin Ophthalmol. 2012. PMID: 22331976 Free PMC article.
-
Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy.Mol Vis. 2013 Aug 4;19:1734-46. Print 2013. Mol Vis. 2013. PMID: 23922491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous